EPA

EPA Struktur
73167-03-0
CAS-Nr.
73167-03-0
Englisch Name:
EPA
Synonyma:
EPA;ICOSAPENT;C20:5 OMEGA-3;TIMNODONIC ACID;Icosapent sodium;EICOSAPENTAENOIC CID;EICOSAPENTAENOIC ACID;EPA 5C,8C,11C,14C,17C;ALL CIS 5-8-11-14-17 EPA;Eicosapentaenoic Acid (sodium)
CBNumber:
CB0162096
Summenformel:
C20H29O2.Na
Molgewicht:
324.44
MOL-Datei:
73167-03-0.mol

EPA Eigenschaften

Schmelzpunkt:
−54-−53 °C(lit.)
Dichte
0.943 g/mL at 25 °C(lit.)
Brechungsindex
n20/D 1.4977(lit.)
storage temp. 
-20°C
Löslichkeit
Ethanol: 1.5 mg/ml; Ethanol:PBS(pH 7.2) (1:5): 0.5 mg/ml
Aggregatzustand
waxy solid
Farbe
white

Sicherheit

Kennzeichnung gefährlicher C
R-Sätze: 34
S-Sätze: 26-36/37/39-45
RIDADR  UN 3265 8/PG 3
WGK Germany  3
8-10-23

EPA Chemische Eigenschaften,Einsatz,Produktion Methoden

R-Sätze Betriebsanweisung:

R34:Verursacht Verätzungen.

S-Sätze Betriebsanweisung:

S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.
S36/37/39:Bei der Arbeit geeignete Schutzkleidung,Schutzhandschuhe und Schutzbrille/Gesichtsschutz tragen.
S45:Bei Unfall oder Unwohlsein sofort Arzt zuziehen (wenn möglich, dieses Etikett vorzeigen).

Verwenden

cis-5,8,11,14,17-Eicosapentaenoic acid sodium salt has been used:
  • to study its effect on the pathology of lupus in drug-induced and spontaneous mouse models
  • to pretreat mouse alveolar macrophages to study the effect/relationship between amiodarone and eicosapentaenoic acid (EPA) concerning the cytokine release
  • to examine if pharmacological correction with EPA supplementation might restore autophagic flux and reduce renal lipotoxicity in mice

Allgemeine Beschreibung

Eicosapentaenoic acid (EPA)/timnodonic acid is an omega-3 polyunsaturated fatty acid (PUFA). This long-chain fatty acid is mainly found in fish oil.

Biochem/physiol Actions

Eicosapentaenoic acid (EPA) possesses anti-hyperglycemic, anti-oxidant, anti-hyperlipidemic, and anti-inflammatory properties. It aids in improving vasoreactivity. EPA is capable of suppressing vascular smooth muscle proliferation. It ameliorates pulmonary hypertension by preventing Fyn kinase activity. EPA exhibits a beneficial effect on lipid metabolism. It is used to treat hypercholesterolemia and atherosclerosis.

EPA Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


EPA Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 38)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
3B Pharmachem (Wuhan) International Co.,Ltd. 821-50328103-801 18930552037
3bsc@sina.com China 15848 69
Guangzhou Isun Pharmaceutical Co., Ltd 020-39119399 18927568969
isunpharm@qq.com China 4428 55
Yichang Zhongyitai Trading Co., Ltd. 0717-6449896 13886658719
root@zhongyitai.com China 1977 58
Sigma-Aldrich 021-61415566 800-8193336
orderCN@merckgroup.com China 51471 80
Wuhan FengyaoTonghui Chemical Products Co., Ltd. 027-87466105 15377573527
2678564200@qq.com China 17997 58
Shanghai Hongye Biotechnology Co. Ltd 400-9205774
sales@glpbio.cn China 6870 58
Guangdong wengjiang Chemical Reagent Co., Ltd. 0751-2815688 13927872512
3007421951@qq.com China 10060 58
Shenzhen Polymeri Biochemical Technology Co., Ltd. +86-400-002-6226
sales@rrkchem.com China 56077 58
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767
sales@chemegen.com China 11289 58
Aleshan (Guangzhou) Biotechnology Co., Ltd 18636736628
Araratbio@163.com China 3342 58

  • 5C,8C,11C,14C,17C-EICOSAPENTAENOIC ACID
  • 5,8,11,14,17-EICOSAPENTAENOIC ACID
  • 5Z,8Z,11Z,14Z,17Z-EICOSAPENTAENOIC ACID
  • ALL CIS-5,8,11,14,17-EICOSAPENTAENOIC ACID
  • ALL CIS 5-8-11-14-17 EPA
  • ALL CIS-5,8,11,14,17-ICOSAPENTAENOIC ACID
  • C20:5 (ALL CIS-5,8,11,14,17) ACID
  • C20:5 OMEGA-3
  • EICOSA-5Z,8Z,11Z,14Z,17Z-PENTAENOIC ACID
  • EICOSAPENTAENOIC ACID
  • EICOSAPENTAENOIC CID
  • EPA
  • EPA 5C,8C,11C,14C,17C
  • CIS-5,8,11,14,17-EICOSAPENTAENOIC ACID
  • CIS-5,8,11,14,17-EICOSAPENTAENOIC ACID SODIUM SALT
  • ICOSAPENT
  • TIMNODONIC ACID
  • cis-5,8,11,14,17-eicosapentaenoic acid*sodium app
  • CIS-5,8,11,14,17-EICOSAPENTAENOIC ACID*S ODIUM APPRO
  • CIS-5,8,11,14,17-EICOSAPENTANEOIC ACID
  • 5,8,11,14,17-eicosapentaenoic acid, sodium salt
  • (5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid sodium salt
  • (all-Z)-5,8,11,14,17-Eicosapentaenoic acid sodium salt
  • tissue inhibitor of metalloproteinase 1 (erythroid potentiating activity
  • 5,8,11,14,17-Eicosapentaenoicacid, sodium salt (1:1), (5Z,8Z,11Z,14Z,17Z)-
  • Eicosapentaenoic Acid (sodium salt)
  • sodium:(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
  • Icosapent sodium
  • Eicosapentaenoic Acid (sodium)
  • 73167-03-0
  • CH3CH2CHCH5CH23CO2Na
  • Higher Fatty Acids & Higher Alcohols
  • Unsaturated Higher Fatty Acids
  • BioChemical
  • Alphabetic
  • Analytical Chromatography Product Catalog
  • Analytical Standards
  • Biochemicals and Reagents
  • Unsaturated fatty acids and derivatives
  • Lipids
  • Lipoxygenase (5-)
  • L to O
  • Polyunsaturated
  • Omega 3 fatty acids and derivatives
  • Fatty Acids
  • Enzyme Inhibitors
  • EA - EO
  • Enzymes, Inhibitors, and Substrates
  • Enzyme Inhibitors by Enzyme
  • Lipoxygenase (5-)Unsaturated fatty acids and derivatives
  • LipoxygenaseEnzyme Inhibitors by Enzyme
  • Omega 3 fatty acids and derivativesBiochemicals Found in Plants
  • Arachidonic Acid Cascade
  • Enzyme Inhibitors
  • L to
  • Lipids
  • Polyunsaturated
Copyright 2019 © ChemicalBook. All rights reserved